Vogelzang, Nicholas J <br/><br/>
Signal-transduction inhibitors in renal cell carcinoma.  [electronic resource] 

 -  BJU international  May 2007 
 - 1289-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1464-4096 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-410X.2007.06833.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Trials, Phase II as Topic<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Signal Transduction--drug effects<br/>Treatment Outcome